• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

06/01/2026 19:13

Remus Pharmaceutic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

Remus Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 76 of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025